
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf is positioned for fundamental improvement because leadership-backed estimates already appear derisked through next year, while upside remains from Services gross margin expansion, lower operating expense, and better price capture. The company’s Banking franchise is still steady, and its fast-growing North America Retail business, including Smart Vision AI and self-checkout wins, is driving double-digit POS growth and helping offset tougher ePOS comparisons. Financially, 2026 adjusted EBITDA is estimated at $495M versus $520M in 2027, FCF is expected to rise from about $150M to $225M, and net leverage below 1.5x supports buybacks and strategic flexibility.
Bears say
Diebold Nixdorf is facing a weak fundamental setup because its banking and retail businesses are exposed to lumpy upgrade cycles, falling ATM demand, and intensifying competition from digital and alternative payment methods. Despite CQ3 revenue of $991M, adjusted EBITDA of $128M, and adjusted EPS of $1.34 beating estimates, management cut 2026 guidance to $3.86B-$3.90B revenue, $490M-$510M EBITDA, and $190M-$210M FCF as mix shifts, memory inflation, and delayed banking deals pressure margins and cash generation. The deterioration in non-GAAP corporate gross margin to 25.3%, retail gross margin to 20.7%, and the loss of targeted service margin expansion suggest pricing power remains limited and the earnings recovery is being pushed further out.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Diebold Nixdorf Inc (DBD) Forecast
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares